Watanabe M - Search Results

1

Melatonin ameliorates angiotensin II-induced vascular endothelial damage via its antioxidative properties.

Nakao T, Morita H, Maemura K, Amiya E, Inajima T, Saito Y, Watanabe M, Manabe I, Kurabayashi M, Nagai R, Komuro I. Nakao T, et al. Among authors: watanabe m. J Pineal Res. 2013 Oct;55(3):287-93. doi: 10.1111/jpi.12071. Epub 2013 Jul 1. J Pineal Res. 2013. PMID: 23815626

2

Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2alpha and Mrf2beta.

Watanabe M, Layne MD, Hsieh CM, Maemura K, Gray S, Lee ME, Jain MK. Watanabe M, et al. Circ Res. 2002 Sep 6;91(5):382-9. doi: 10.1161/01.res.0000033593.05545.7b. Circ Res. 2002. PMID: 12215486

3

Genetic variations of Mrf-2/ARID5B confer risk of coronary atherosclerosis in the Japanese population.

Wang G, Watanabe M, Imai Y, Hara K, Manabe I, Maemura K, Horikoshi M, Kohro T, Amiya E, Sugiyama T, Fujita T, Kadowaki T, Yamazaki T, Nagai R. Wang G, et al. Among authors: watanabe m. Int Heart J. 2008 May;49(3):313-27. doi: 10.1536/ihj.49.313. Int Heart J. 2008. PMID: 18612189 Free article.

4

Efficacy of renal revascularization in a patient with fibromuscular renal artery stenosis and heart failure.

Uchino Y, Watanabe M, Hirata Y, Shigematsu K, Miyata T, Nagai R. Uchino Y, et al. Among authors: watanabe m. Int Heart J. 2010;51(6):432-5. doi: 10.1536/ihj.51.432. Int Heart J. 2010. PMID: 21173521 Free article.

5

Successful blood sampling through azygos continuation with interrupted inferior vena cava. A case report and review of the literature.

Saito T, Watanabe M, Kojima T, Matsumura T, Fujita H, Kiyosue A, Takahashi M, Takeda N, Maemura K, Yamashita H, Hirata Y, Komatsu S, Ohtomo K, Nagai R. Saito T, et al. Among authors: watanabe m. Int Heart J. 2011;52(5):327-30. doi: 10.1536/ihj.52.327. Int Heart J. 2011. PMID: 22008446 Free article. Review.

6

Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases.

Takahashi T, Asano Y, Amiya E, Hatano M, Tamaki Z, Ozeki A, Watanabe A, Kawarasaki S, Nakao T, Taniguchi T, Ichimura Y, Toyama T, Watanabe M, Hirata Y, Nagai R, Sato S. Takahashi T, et al. Among authors: watanabe m, watanabe a. Mod Rheumatol. 2012 Aug;22(4):598-601. doi: 10.1007/s10165-011-0545-1. Epub 2011 Oct 21. Mod Rheumatol. 2012. PMID: 22015621

7

Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.

Kato N, Kinugawa K, Shiga T, Hatano M, Takeda N, Imai Y, Watanabe M, Yao A, Hirata Y, Kazuma K, Nagai R. Kato N, et al. Among authors: watanabe m. J Cardiol. 2012 Jul;60(1):23-30. doi: 10.1016/j.jjcc.2012.01.010. Epub 2012 Mar 21. J Cardiol. 2012. PMID: 22445598 Free article.

8

Associations of variations in the MRF2/ARID5B gene with susceptibility to type 2 diabetes in the Japanese population.

Wang G, Watanabe M, Imai Y, Hara K, Manabe I, Maemura K, Horikoshi M, Ozeki A, Itoh C, Sugiyama T, Kadowaki T, Yamazaki T, Nagai R. Wang G, et al. Among authors: watanabe m. J Hum Genet. 2012 Nov 26;57(11):727-33. doi: 10.1038/jhg.2012.101. Epub 2012 Sep 13. J Hum Genet. 2012. PMID: 22971728

9

Simultaneous heart rate variability monitoring enhances the predictive value of flow-mediated dilation in ischemic heart disease.

Watanabe S, Amiya E, Watanabe M, Takata M, Ozeki A, Watanabe A, Kawarasaki S, Nakao T, Hosoya Y, Omori K, Maemura K, Komuro I, Nagai R. Watanabe S, et al. Among authors: watanabe m, watanabe a. Circ J. 2013;77(4):1018-25. doi: 10.1253/circj.cj-12-1043. Epub 2012 Dec 14. Circ J. 2013. PMID: 23238368 Free article. Clinical Trial.

10

Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART study.

Yamazaki T, Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Yamazaki T, et al. Int Heart J. 2013;54(1):33-9. doi: 10.1536/ihj.54.33. Int Heart J. 2013. PMID: 23428922 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,146 results

Search Page

Filters